Analystreport

Health Catalyst (NASDAQ:HCAT) had its "neutral" rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $4.00 price target on the stock.

Health Catalyst, Inc - Common stock  (HCAT) 
Last health catalyst, inc - common stock earnings: 2/27 04:05 pm Check Earnings Report